174 related articles for article (PubMed ID: 21701492)
41. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
[TBL] [Abstract][Full Text] [Related]
42. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
Petrucci MT; De Felice L; Ricciardi MR; Ariola C; Mascolo MG; Fenu S; Tafuri A
Cytokines Mol Ther; 1996 Dec; 2(4):225-30. PubMed ID: 9384708
[TBL] [Abstract][Full Text] [Related]
43. Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.
Wu S; Gessner R; Taube T; Korte A; von Stackelberg A; Kirchner R; Henze G; Seeger K
J Pediatr Hematol Oncol; 2006 Apr; 28(4):216-20. PubMed ID: 16679918
[TBL] [Abstract][Full Text] [Related]
44. Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice.
Palucka AK; Scuderi R; Porwit A; Jeha S; Gruber A; Björkholm M; Beran M; Pisa P
Leukemia; 1996 Mar; 10(3):558-63. PubMed ID: 8642875
[TBL] [Abstract][Full Text] [Related]
45. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
Khan NI; Bradstock KF; Bendall LJ
Br J Haematol; 2007 Aug; 138(3):338-48. PubMed ID: 17614820
[TBL] [Abstract][Full Text] [Related]
46. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
Castro FV; McGinn OJ; Krishnan S; Marinov G; Li J; Rutkowski AJ; Elkord E; Burt DJ; Holland M; Vaghjiani R; Gallego A; Saha V; Stern PL
Leukemia; 2012 Jul; 26(7):1487-98. PubMed ID: 22266911
[TBL] [Abstract][Full Text] [Related]
47. Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
Rhein P; Scheid S; Ratei R; Hagemeier C; Seeger K; Kirschner-Schwabe R; Moericke A; Schrappe M; Spang R; Ludwig WD; Karawajew L
Leukemia; 2007 May; 21(5):897-905. PubMed ID: 17330098
[TBL] [Abstract][Full Text] [Related]
48. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
[TBL] [Abstract][Full Text] [Related]
49. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
50. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
Qian W; Liu J; Tong Y; Yan S; Yang C; Yang M; Liu X
Leukemia; 2008 Feb; 22(2):361-9. PubMed ID: 18046450
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells.
Cocco C; Canale S; Frasson C; Di Carlo E; Ognio E; Ribatti D; Prigione I; Basso G; Airoldi I
Blood; 2010 Nov; 116(19):3887-98. PubMed ID: 20671120
[TBL] [Abstract][Full Text] [Related]
52. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs.
Fox JM; Moynihan JR; Mott BT; Mazzone JR; Anders NM; Brown PA; Rudek MA; Liu JO; Arav-Boger R; Posner GH; Civin CI; Chen X
Oncotarget; 2016 Feb; 7(6):7268-79. PubMed ID: 26771236
[TBL] [Abstract][Full Text] [Related]
53. Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.
van der Sligte NE; Kampen KR; ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Guryev V; van Leeuwen FN; Kornblau SM; de Bont ES
Oncotarget; 2015 Jun; 6(17):14970-81. PubMed ID: 26008971
[TBL] [Abstract][Full Text] [Related]
54. Significance of BAFF/APRIL Expression and Their Receptors in Pediatric Patients With Acute Lymphoblastic Leukemia.
Sun B; Li L; Xu M; Wang X; Wang F; Ni H
J Pediatr Hematol Oncol; 2016 Apr; 38(3):167-72. PubMed ID: 26950089
[TBL] [Abstract][Full Text] [Related]
55. miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia.
Lyu X; Li J; Yun X; Huang R; Deng X; Wang Y; Chen Y; Xiao G
Oncol Rep; 2017 Mar; 37(3):1469-1476. PubMed ID: 28184923
[TBL] [Abstract][Full Text] [Related]
56. Hoechst 33342 Staining Identifies the Progenitor Side Population in NOD.Cg-PrkdcscidIL2rgtmWjl/Sz Mice Harboring Pediatric Leukemias.
Andre MC; Witte KE; Hoerrmann RA; Schmitt A; Handgretinger R; Ebinger M
In Vivo; 2015; 29(6):661-9. PubMed ID: 26546522
[TBL] [Abstract][Full Text] [Related]
57. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
Velázquez-Avila M; Balandrán JC; Ramírez-Ramírez D; Velázquez-Avila M; Sandoval A; Felipe-López A; Nava P; Alvarado-Moreno JA; Dozal D; Prieto-Chávez JL; Schaks M; Rottner K; Dorantes-Acosta E; López-Martínez B; Schnoor M; Pelayo R
Leukemia; 2019 Jun; 33(6):1337-1348. PubMed ID: 30573781
[TBL] [Abstract][Full Text] [Related]
58. L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.
Rosilio C; Nebout M; Imbert V; Griessinger E; Neffati Z; Benadiba J; Hagenbeek T; Spits H; Reverso J; Ambrosetti D; Michiels JF; Bailly-Maitre B; Endou H; Wempe MF; Peyron JF
Leukemia; 2015 Jun; 29(6):1253-66. PubMed ID: 25482130
[TBL] [Abstract][Full Text] [Related]
59. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
60. Cytokines, growth, and environment factors in bone marrow plasma of acute lymphoblastic leukemia pediatric patients.
Kováč M; Vášková M; Petráčková D; Pelková V; Mejstříková E; Kalina T; Žaliová M; Weiser J; Starý J; Hrušák O
Eur Cytokine Netw; 2014 Mar; 25(1):8-13. PubMed ID: 24998352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
